Contact

2025 Outlook – Life Sciences

23 January 2025

For the final installment in Vynamic’s 2025 health industry outlook series, Jen is joined by Vynamic’s Head of Life Sciences, Karen Baldry, and Head of Life Sciences Europe, Gemma Pfister, to focus on the Life Sciences industry – the trends most impacting the pharmaceutical and biotech sectors.

 

To learn more about Vynamic’s overall 2025 Health Industry Outlook, visit: https://vynamic.com/insights/navigating-turbulence-and-transformation-2025-health-industry-outlook/  

 

Podcast Tags: healthcare, healthcare news, life sciences, pharmaceutical, biotech, Inflation Reduction Act, product launch, direct-to-consumer, pharmacy, integrated delivery networks 

 

Panel – Karen Baldry, Gemma Pfister, Jen Burke 

Research & Production – Jen Burke, Mindy McGrath 

Recording & Editing – Mike Liberto, Rachel Skonecki 

 

For additional discussion, please contact us at TrendingHealth.com.

Next Podcast

27 February 2025

European Healthcare Innovation Roadshow: Barcelona’s rise as a digital health hub

Listen to podcast

Previous Podcast

16 January 2025

2025 Outlook – Health Services

Listen to podcast

Listen now

The State of Life Sciences – An Industry Perspective

As we kick off 2026, Mindy sits down with Inizio Ignite Global President, Remco op den Kelder, to discuss the industry...

Listen now

The 2025 Launch Landscape: Finding Stability in a System Under Pressure

The rules of product launch are changing fast. Policy reform, payer pressure, AI adoption, and shifting system dynamics...

Listen now

Direct by Design: Pharma’s Next Channel is the Patient

The traditional path to patients is being rewritten. As affordability pressures rise and patient expectations shift,...

Listen now